Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the breadth of possibilities for treating this disease. Using a comprehensive approach that included integrating proteomics, genomics and epigenomics data from 10 cancer types, the team identified protein and small protein or peptide targets in cancer tissues and validated many of them experimentally as promising candidates for therapeutic strategies. The study appeared in Cell.
Former Schrödinger exec launches RA Capital-backed startup for AI drug discovery
Superluminal Medicines, a startup claiming that it can use artificial intelligence to shrink the development of preclinical drug candidates from years to a matter of
August 29, 2023